Photos from November 19 show Second Lady Usha Vance without her wedding ring during a visit to Camp Lejeune with First Lady Melania Trump, fueling online speculation about her marriage. The rumors follow October chatter after Vice President JD Vance publicly said he hoped his Hindu wife would convert to Catholicism. A spokesperson dismissed the gossip, explaining she often forgets the ring while caring for their three young children. Despite viral images, other recent photos show her wearing the band, making the split rumors unproven.
JD Vance converted to Catholicism in 2019 after being raised Protestant, while his wife Usha Vance (born Chilukuri) is a practicing Hindu from an Indian-American family. They married in 2014 and had both a civil ceremony and a Hindu Vivaha ritual to honor her faith. Usha has said she never intended to convert, and the couple agreed to raise their children with exposure to both traditions, though they currently attend Catholic school. JD Vance has publicly expressed hope that she might one day embrace Christianity, but he emphasizes respect for her beliefs.
Consumer watchdogs warn that some AI-powered toys can engage kids in sexually explicit conversations and even suggest where to find knives or matches. The U.S. PIRG’s latest Trouble in Toyland report found toys built on large language models often bypass safety guardrails after minutes of interaction. One plush bear discussed sexual kinks and gave dangerous advice, prompting its maker to suspend sales. Experts also highlight privacy risks, as many toys record voices, collect birth dates, and use facial recognition.
Eli Lilly became the first pharmaceutical company to hit a $1 trillion market value, driven by surging demand for its weight-loss and diabetes drugs Mounjaro and Zepbound. These GLP-1 treatments generated over $10 billion last quarter, more than half of Lilly’s $17.6 billion revenue. Shares have soared 35% this year, reflecting investor confidence as analysts project the obesity drug market could reach $150 billion by 2030. Lilly plans to launch an oral version next year, aiming to cement its lead over rival Novo Nordisk.
Novo Nordisk is Eli Lilly’s main rival in the booming obesity drug market. Novo pioneered GLP-1 therapy with Ozempic and Wegovy, generating $18.4 billion in GLP-1 revenue in 2023 versus Lilly’s $5.2 billion. Novo currently holds about 62% of the obesity drug market, while Lilly has roughly 28%, but Lilly’s growth is far faster – up 200% year-over-year compared to Novo’s 35%.
President Volodymyr Zelensky warned Ukraine faces a stark choice: accept a U.S.-drafted peace plan that includes Russian territorial concessions or risk losing Washington as a key ally. The 28-point proposal, backed by President Trump, blocks NATO membership and demands Ukraine reduce its army, while offering limited security guarantees. Zelensky insists on a “dignified peace” that protects sovereignty, but admits pressure is “one of the hardest” moments in Ukraine’s history. European leaders pledged support, yet the U.S. set a Thursday deadline for Kyiv’s response.
